Covid-19 roundup: Mod­er­na sends in EUA for bi­va­lent teen boost­er; US trim­ming Pfiz­er/BioN­Tech do­na­tions

Though Mod­er­na’s bi­va­lent vac­cine to counter the Omi­cron vari­ant has cleared the ini­tial hur­dles in get­ting FDA au­tho­riza­tion, the vac­cine mak­er is mov­ing on to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.